| 
 
		临床适应症 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|  |  | 
| Pre | Post | 
子宫肌瘤栓塞
Concerns:
	      - Target perifibroid plexus (500-800μm)
	      - Minimize myometrial damage & passage through U-O anastomosis
Conventional
	       - PVA (Contour) 355-500, 500-710μm
	       - Gelatin particles 1-2mm
Microspheres
- Embosphere ≥500-700μm
		                  - limited (pruned tree)
	- Others ≥700-900μm
		                  - near stasis
	X Soft spherical-PVA (Contour SE)
		                   - incomplete infarction
	|  |  | 
| 术前 | 术后3个月 | 
Caution for Small Microspheres
		H&N, MSK, bronchial, GI, etc.
	
		       Deep penetration has risks:
	- Inadvertent cerebral or spinal artery embolization via dangerous anastomosis
- Systemic (paradoxical) embolization through AV shunts
- Ischemic damage of mucosa or bronchial wall
|  | 
| 
						Dog small bowel / Embosphere 100-300 | 
Kishimoto K, et al. J Vasc Interv Radiol 2014; 25:1767–1773
Tips & pitfalls (especially for microspheres)
Microspheres Are Not the Same
|  |  |  | 
|  |  |  | 
| 
						Round | Round | Expand & deform | 
|  |  | 
|  |  | 
| Ova | 
						flattened | 
Final Location Depends on Mechanical Property
| Final Location | 
						Elasticity /  compressibility | 
|  | High | 
|  | Middle | 
|  | Low | 
Redistribution of Microspheres
|  | |
|  | 
						Aggregation | 
|  | 
						Re-check after 5-10min 
						Redistribution 
							Recanalization | 
Adequate Dilution & Slow Injection
|  |  | 
| 
						Especially when 
						Using small size 
						In small arteries 
						In slow-flow condition | 
						Homogeneous suspension 
						1mL-luer lock syringe 
						Very slow injection 
						Under “free-flow” | 
 New concepts (WIP)
 可吸收微球 Resorbable microspheres
Rationale:
- 
		作为异物,微粒在栓塞后不再被需要 As foreign body, particles are not needed after the effect is obtained.
- 在理想的情况下,伴随有控制的吸收时间,和有限的炎症,血管的完整性和药物荷载能力重新恢复
Products or WIP (few clinical data):
| 
 |  | 
|  |  |  |  | 
| 当天 | 3天 | 9天 | 14天 | 
		
		血管完整性恢复 Restoration of Vessel Integrity
	ResMic
|  |  | 
| 0天 | 7天 | 
Occlusin 503
|  |  |  | 
		                                                            Owen RJ, et al. CVIR2012;35:636-644;Maeda N, et al. JVIR 2013;24:1391-98
	 可视微球 Visible (radiopaque) microspheres
- 微球的可见性将有助于实时监测微粒释放的情况,并应用CT或MRI下评估它们的分布。
	Visibility of microspheres would help for real-time  monitoring of delivery and also evaluation of distribution  under CT or MRI.
- WIIP
		                 Polyzene-F coated with barium sulfate 硫酸钡包裹的聚锌-F
	
		                 MRI visible amonafide-eluting arginate microspheres  etc.  MRI可见氨奈菲特了(抗肿瘤药)洗脱精氨酸微球等。
Sharma KVJ, et al. JVIR 2010;21:865-876
	Stampfl U, et al. JVIR 2012;23:1225-1231
	Kim DH, et al.Theranostics 2015;5:477-488
	
	
	
		
			
	
	
	
	
		
			
|  |  |  | 
| 
						HepaSphere 150-200 
						(expanded size 600-800) | 术前 | 术后 | 
		 Real-time monitoring of particle distribution or passage through the nidus
	|  |  | 
| 术前 | 术后6个月 | 
总结
		  用味道管的微粒栓塞,广泛应用于各种器官或靶向部位,Microparticles are widely used in various organs or locations for targeted embolization with a microcatheter.
		
		 
	
		 了解每一种所选择栓塞微粒的物理特性和表现都很重要。It is important to understand each physical property and behavior in choice of materials.
		
		 
	
		   熟悉正确的处理方法,包括稀释,注射和大小选择。Be familiar with correct handling including dilution, injection, and size selection.

 
        
      
